A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies

Harrell W Chesson; Thomas L Gift; Kwame Owusu-Edusei Jr; Guoyu Tao; Ana P Johnson; Charlotte K Kent

doi:10.1097/OLQ.0b013e318223be77

A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies

Sex Transm Dis. 2011 Oct;38(10):889-91. doi: 10.1097/OLQ.0b013e318223be77.

Authors

Harrell W Chesson¹, Thomas L Gift, Kwame Owusu-Edusei Jr, Guoyu Tao, Ana P Johnson, Charlotte K Kent

Affiliation

¹ Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA. hbc7@cdc.gov

PMID: 21934557
DOI: 10.1097/OLQ.0b013e318223be77

Abstract

We conducted a literature review of studies of the economic burden of sexually transmitted diseases in the United States. The annual direct medical cost of sexually transmitted diseases (including human immunodeficiency virus) has been estimated to be $16.9 billion (range: $13.9-$23.0 billion) in 2010 US dollars.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Cost of Illness*
Humans
Inflation, Economic
Sexually Transmitted Diseases / economics*
United States